Hemoglobin crosslinkers
    1.
    发明授权
    Hemoglobin crosslinkers 失效
    血红蛋白交联剂

    公开(公告)号:US6017943A

    公开(公告)日:2000-01-25

    申请号:US18284

    申请日:1998-02-04

    摘要: The present invention provides a class of compounds having the formula:Y--R--CH.sub.2 --CH.sub.2 --[O--CH.sub.2 --CH.sub.2 ].sub.n --R'--Y'wherein n is an integer from about 5 to about 200; R is carbamate, urea, or amide; R' is carbamate, urea, amide, or oxygen; Y is 4-phenylmalemimido or 3-phenylmaleimido; and Y' is 4-phenylmalemimido, 3-phenylmaleimido, methyl or hydrogen. The present invention also provides various hemoglobin compositions modified with the class of compounds of the present invention, processes for preparing these compositions, as well as pharmaceutical compositions comprising these compositions.

    摘要翻译: 本发明提供一类具有下式的化合物:Y-R-CH 2 -CH 2 - [O-CH 2 -CH 2] n -R'-Y',其中n为约5至约200的整数; R为氨基甲酸酯,脲或酰胺; R'是氨基甲酸酯,脲,酰胺或氧; Y是4-苯基亚氨代酰亚氨基或3-苯基马来酰亚胺基; 并且Y'是4-苯基亚氨基亚氨基,3-苯基马来酰亚氨基,甲基或氢。 本发明还提供了用本发明化合物类别修饰的各种血红蛋白组合物,这些组合物的制备方法以及包含这些组合物的药物组合物。

    Hemoglobin crosslinkers
    2.
    发明授权
    Hemoglobin crosslinkers 失效
    血红蛋白交联剂

    公开(公告)号:US5585484A

    公开(公告)日:1996-12-17

    申请号:US425137

    申请日:1995-04-19

    摘要: The present invention provides a class of compounds having the formula:Y--R--CH.sub.2 --CH.sub.2 --[O--CH.sub.2 --CH.sub.2 ].sub.n --R'--y'wherein n is an integer from about 5 to about 200; R is carbamate, urea, or amide; R' is carbamate, urea, amide, or oxygen; Y is 4-phenylmalemimido or 3-phenylmaleimido; and Y' is 4-phenylmalemimido, 3-phenylmaleimido, methyl or hydrogen. The present invention also provides various hemoglobin compositions modified with the class of compounds of the present invention, processes for preparing these compositions, as well as pharmaceutical compositions comprising these compositions.

    摘要翻译: 本发明提供一类具有下式的化合物:Y-R-CH 2 -CH 2 - [O-CH 2 -CH 2] n -R'-y',其中n为约5至约200的整数; R是氨基甲酸酯,脲或酰胺; R'是氨基甲酸酯,脲,酰胺或氧; Y是4-苯基亚氨代酰亚氨基或3-苯基马来酰亚胺基; 并且Y'是4-苯基亚氨基亚氨基,3-苯基马来酰亚氨基,甲基或氢。 本发明还提供了用本发明化合物类别修饰的各种血红蛋白组合物,这些组合物的制备方法以及包含这些组合物的药物组合物。

    Site specific pegylated hemoglobin, method of preparing same, and uses thereof
    3.
    发明申请
    Site specific pegylated hemoglobin, method of preparing same, and uses thereof 审中-公开
    场地特异性聚乙二醇化血红蛋白,其制备方法及其应用

    公开(公告)号:US20090215670A1

    公开(公告)日:2009-08-27

    申请号:US11919788

    申请日:2006-05-10

    IPC分类号: A61K38/42 C07K14/805

    CPC分类号: C07K14/805

    摘要: The present invention provides pegylated hemoglobins comprising a maleimide polyethylene glycol (PEG) conjugated to a thiol moiety of a cysteine residue of hemoglobin, methods of preparing the pegylated hemoglobins, compositions and blood substitutes comprising the pegylated hemoglobins, and methods of treating a subject which comprise administering to the subject blood substitutes comprising vasoinactive pegylated hemoglobins.

    摘要翻译: 本发明提供了包含与血红蛋白的半胱氨酸残基的硫醇部分缀合的马来酰亚胺聚乙二醇(PEG)的聚乙二醇化血红蛋白,制备聚乙二醇化血红蛋白的方法,包含聚乙二醇化血红蛋白的组合物和血液代用品,以及治疗受试者的方法, 向受试者施用包含血管活性聚乙二醇化血红蛋白的血液代用品。

    Modified hemoglobin and methods of making same
    4.
    发明授权
    Modified hemoglobin and methods of making same 有权
    改良血红蛋白及其制备方法

    公开(公告)号:US07501499B2

    公开(公告)日:2009-03-10

    申请号:US10538976

    申请日:2003-12-18

    IPC分类号: G01N33/72 C08H1/00 A61K38/00

    摘要: The present invention provides a hemoglobin molecule (Hb) having six ± one PEG chains, wherein two of said PEG chains are bound to Cys-93 (β) of Hb, and the remaining PEG chains are bound to thiol groups introduced on ε-NH2 of Hb. The present invention also provides a process for preparing a modified hemoglobin molecule (Hb), comprising the steps of: (a) reacting Hb with 8-15 fold excess of iminothiolane to form thiolated Hb; and (b) reacting the thiolated Hb with 16-30 fold excess of PEG functionalized with a maleimide moiety, to form the modified Hb.

    摘要翻译: 本发明提供了具有6个±1个PEG链的血红蛋白分子(Hb),其中两个所述PEG链与Hb的Cys-93(β)结合,其余的PEG链与引入到ε-NH 2上的硫醇基结合 的Hb。 本发明还提供了制备修饰的血红蛋白分子(Hb)的方法,包括以下步骤:(a)使Hb与8-15倍过量的亚氨基四氢噻吩反应以形成硫醇化的Hb; 和(b)使硫醇化的Hb与用马来酰亚胺部分官能化的16-30倍过量的PEG反应,形成改性的Hb。

    Pegylated non-hypertensive hemoglobins, methods of preparing same, and uses thereof
    5.
    发明授权
    Pegylated non-hypertensive hemoglobins, methods of preparing same, and uses thereof 有权
    聚乙二醇化非高血压血红蛋白,其制备方法及其应用

    公开(公告)号:US07144989B2

    公开(公告)日:2006-12-05

    申请号:US10957200

    申请日:2004-10-01

    IPC分类号: A61K38/42 C07K14/805 C07K1/00

    摘要: The present invention provides pegylated hemoglobins comprising a thiocarbamoyl-phenyl-polyethylene glycol (PEG) attached to hemoglobin, and comprising a polyethylene glycol (PEG) attached to hemoglobin by an acyl group. The invention also provides methods of preparing pegylated hemoglobins using isothiocyanato phenyl carbamate of PEG and using isothiocyanato phenyl di-PEG carbamate. The invention further provides compositions and blood substitutes comprising pegylated hemoglobins and methods of treating a subject which comprise administering to the subject blood substitutes comprising non-hypertensive pegylated hemoglobins.

    摘要翻译: 本发明提供了包含与血红蛋白连接的硫代氨基甲酰基 - 苯基 - 聚乙二醇(PEG)的聚乙二醇化血红蛋白,并且包含通过酰基与血红蛋白连接的聚乙二醇(PEG)。 本发明还提供使用PEG的异硫氰酸苯酯基氨基甲酸酯制备聚乙二醇化血红蛋白的方法,并使用异硫氰酸苯酯二PEG-氨基甲酸酯。 本发明进一步提供了包含聚乙二醇化血红蛋白的组合物和血液代用品以及治疗受试者的方法,其包括向所述受试者施用包含非高血压聚乙二醇化血红蛋白的血液替代物。

    PEGYLATED HEMOGLOBIN AND ALBUMIN AND USES THEREOF
    6.
    发明申请
    PEGYLATED HEMOGLOBIN AND ALBUMIN AND USES THEREOF 审中-公开
    聚乙二醇和铝及其用途

    公开(公告)号:US20140256636A1

    公开(公告)日:2014-09-11

    申请号:US14281970

    申请日:2014-05-20

    IPC分类号: C07K14/805 C07K14/765

    摘要: The present invention provides PEGylated hemoglobins and PEGylated albumins comprising polyethylene glycol (PEG) conjugated to hemoglobin or to albumin, wherein the PEG is a maleimide PEG, an alkylamide PEG, an iodoacetamide PEG, a p-nitro thio-phenyl PEG, a vinyl sulfone PEG, or a mixed disulfide PEG; and PEGylated albumins and PEGylated hemoglobins comprising polyethylene glycol (PEG) attached to a thiolated amino group of albumin or hemoglobin, wherein the amino group is thiolated using dithio sulfo succinimidyl propionate (DTSSP) or dithiosuccinimidyl propionate (DTSP) or dithiobispropionimidate. The invention also provides methods of preparing PEGylated hemoglobins and PEGylated albumins comprising a) reacting hemoglobin or albumin with a thiolating agent and with a PEGylating agent, and b) capping unPEGylated reactive thiols of hemoglobin or albumin with N-ethyl maleimide.

    摘要翻译: 本发明提供聚乙二醇化的血红蛋白和聚乙二醇化的白蛋白,其包含与血红蛋白或白蛋白缀合的聚乙二醇(PEG),其中PEG是马来酰亚胺PEG,烷基酰胺PEG,碘乙酰胺PEG,对硝基硫代苯基PEG,乙烯基砜 PEG或混合二硫化物PEG; 和聚乙二醇化的白蛋白和聚乙二醇化血红蛋白,其包含连接到白蛋白或血红蛋白的硫醇化氨基的聚乙二醇(PEG),其中使用二硫代磺基琥珀酰亚胺基丙酸酯(DTSSP)或二硫代琥珀酰亚胺基丙酸酯(DTSP)或二硫代双丙酰亚胺酯来硫化氨基。 本发明还提供制备聚乙二醇化血红蛋白和聚乙二醇化白蛋白的方法,其包括a)使血红蛋白或白蛋白与硫醇化剂和聚乙二醇化剂反应,和b)用N-乙基马来酰亚胺封端血红蛋白或白蛋白的未PEG化的反应性硫醇。

    Universal red blood cells, methods of preparing same, and uses thereof
    7.
    发明授权
    Universal red blood cells, methods of preparing same, and uses thereof 失效
    通用红细胞,其制备方法及其应用

    公开(公告)号:US07521174B2

    公开(公告)日:2009-04-21

    申请号:US11004052

    申请日:2004-12-03

    IPC分类号: A01N1/02

    CPC分类号: C12N5/0641 C12N5/0006

    摘要: The present invention is directed to pegylated red blood cells comprising a polyethylene glycol (PEG) attached to a thiolated amino group on a membrane protein, and to compositions comprising the pegylated red blood cells. The invention also provides methods of preparing pegylated red blood cells comprising reacting red blood cells with a compound that produces a thiolated amino group on a red blood cell membrane protein, and reacting the thiolated red blood cell with a PEG. The invention further provides methods of treatment using pegylated red blood cells.

    摘要翻译: 本发明涉及包含与膜蛋白上的硫醇化氨基连接的聚乙二醇(PEG)的聚乙二醇化红细胞以及包含聚乙二醇化红细胞的组合物。 本发明还提供了制备聚乙二醇化红细胞的方法,包括使红细胞与在红细胞膜蛋白上产生硫醇化氨基的化合物反应,并将硫醇化的红细胞与PEG反应。 本发明进一步提供了使用聚乙二醇化红细胞的治疗方法。

    Size enhanced hemoglobins: surface decoration and crosslinking of the protein with polyoxy alkylene glycols

    公开(公告)号:US07019117B2

    公开(公告)日:2006-03-28

    申请号:US10198732

    申请日:2002-07-18

    IPC分类号: C07K14/805

    CPC分类号: C07K14/805 A61K47/60

    摘要: Novel modified hemoglobins comprising polyalkylene glycols and novel methods for making those hemoglobins are provided. One group of modified hemoglobins comprise polyalkylene glycols bonded to the hemoglobin with an amide linkage at Glu-43(β). Additional polyalkylene glycols can also be bonded to the Glu-22(β) and/or the Asp-47(β). These hemoglobins are made by a novel amidation procedure. A second group of modified hemoglobins comprise a polyalkylene glycol covalently bonded to the hemoglobin at the α-amino of a Val-1(β) or a Val-1(α). Additional polyalkylene glycols can optionally be covalently bonded to a limited number of ε-amino groups. This second group of hemoglobins is made using a novel reductive alkylation procedure. A third group of modified hemoglobins comprise a polyalkylene glycol bonded to a thiol group of the hemoglobin through a phenylsuccinimido linkage, wherein no polyalkylene glycol is bonded to a Cys-93(β). This third group of modified hemoglobins is made by an improvement in a hemoglobin-polyalkylene linkage procedure utilizing thiolation-mediated maleimide chemistry.

    Pegylated hemoglobin and albumin and uses thereof
    10.
    发明申请
    Pegylated hemoglobin and albumin and uses thereof 有权
    聚乙二醇化血红蛋白和白蛋白及其用途

    公开(公告)号:US20090298746A1

    公开(公告)日:2009-12-03

    申请号:US11921064

    申请日:2006-06-09

    摘要: The present invention provides PEGylated hemoglobins and PEGylated albumins comprising polyethylene glycol (PEG) conjugated to hemoglobin or to albumin, wherein the PEG is a maleimide PEG, an alkylamide PEG, an iodoacetamide PEG, a p-nitro thio-phenyl PEG, a vinyl sulfone PEG, or a mixed disulfide PEG; and PEGylated albumins and PEGylated hemoglobins comprising polyethylene glycol (PEG) attached to a thiolated amino group of albumin or hemoglobin, wherein the amino group is thiolated using dithio sulfo succinimidyl propionate (DTSSP) or dithiosuccinimidyl propionate (DTSP) or dithiobispropionimidate. The invention also provides methods of preparing PEGylated hemoglobins and PEGylated albumins comprising a) reacting hemoglobin or albumin with a thiolating agent and with a PEGylating agent, and b) capping unPEGylated reactive thiols of hemoglobin or albumin with N-ethyl maleimide.

    摘要翻译: 本发明提供聚乙二醇化的血红蛋白和聚乙二醇化的白蛋白,其包含与血红蛋白或白蛋白缀合的聚乙二醇(PEG),其中PEG是马来酰亚胺PEG,烷基酰胺PEG,碘乙酰胺PEG,对硝基硫代苯基PEG,乙烯基砜 PEG或混合二硫化物PEG; 和聚乙二醇化的白蛋白和聚乙二醇化血红蛋白,其包含连接到白蛋白或血红蛋白的硫醇化氨基的聚乙二醇(PEG),其中使用二硫代磺基琥珀酰亚胺基丙酸酯(DTSSP)或二硫代琥珀酰亚胺基丙酸酯(DTSP)或二硫代双丙酰亚胺酯来硫化氨基。 本发明还提供制备聚乙二醇化血红蛋白和聚乙二醇化白蛋白的方法,其包括a)使血红蛋白或白蛋白与硫醇化剂和聚乙二醇化剂反应,和b)用N-乙基马来酰亚胺封端血红蛋白或白蛋白的未PEG化的反应性硫醇。